Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2003, v. 5, n. 6, p. 446, doi. 10.1046/j.1463-1326.2003.00300.x

By:

• Christiansen, J.S.;
• Vaz, J.A.;
• Metelko, Z.;
• Bogoev, M.;
• Dedov, I.

Publication type:

Article